Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, STAAR SURGICAL CO reported revenue of $239M, down 23.7% year over year. Operating margin was -38.3% and net margin -33.6%, on a free-cash-flow margin of -16.7% with capital expenditure at 2.4% of revenue. Every figure is computed directly from STAA's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $239M | -38.3% | -33.6% |
| FY2024 | $314M | -4.0% | -6.4% |
| FY2023 | $322M | 8.7% | 6.6% |
| FY2022 | $239M | 18.3% | 16.6% |
| FY2021 | $230M | 14.5% | 11.9% |
How does STAA compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.